Publicaciones en las que colabora con MIGUEL PAYA PERIS (41)

2019

  1. Defective induction of COX-2 expression by psoriatic fibroblasts promotes pro-inflammatory activation of macrophages

    Frontiers in Immunology, Vol. 10, Núm. MAR

2017

  1. Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis

    Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 123-131

2013

  1. NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: In vitro and in vivo effects of BTH

    Journal of Investigative Dermatology, Vol. 133, Núm. 10, pp. 2362-2371

  2. Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-κB and STAT3 in human keratinocytes

    Pharmacological Research, Vol. 70, Núm. 1, pp. 20-26

2011

  1. Perthamides C-F, potent human antipsoriatic cyclopeptides

    Tetrahedron, Vol. 67, Núm. 40, pp. 7780-7786

2010

  1. Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin e synthase-1 enzyme as promising tools in drug development

    Chemical Biology and Drug Design, Vol. 76, Núm. 1, pp. 17-24

2009

  1. Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression

    European Journal of Pharmacology, Vol. 620, Núm. 1-3, pp. 112-119

  2. Coscinolactams A and B: new nitrogen-containing sesterterpenoids from the marine sponge Coscinoderma mathewsi exerting anti-inflammatory properties

    Tetrahedron, Vol. 65, Núm. 15, pp. 2905-2909

2008

  1. Avarol inhibits TNF-α generation and NF-κB activation in human cells and in animal models

    Life Sciences, Vol. 82, Núm. 5-6, pp. 256-264

  2. Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the γ-hydroxybutenolide scaffold

    Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 19, pp. 9056-9064

2007

  1. Antipsoriatic effects of avarol-3′-thiosalicylate are mediated by inhibition of TNF-α generation and NF-αB activation in mouse skin

    British Journal of Pharmacology, Vol. 152, Núm. 3, pp. 353-365

  2. Synthesis and evaluation of diverse thio avarol derivatives as potential UVB photoprotective candidates

    Bioorganic and Medicinal Chemistry Letters, Vol. 17, Núm. 9, pp. 2561-2565

  3. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the γ-hydroxybutenolide scaffold: A new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression

    Journal of Medicinal Chemistry, Vol. 50, Núm. 9, pp. 2176-2184

2006

  1. Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation

    Life Sciences, Vol. 79, Núm. 25, pp. 2395-2404

2005

  1. Búsqueda y evaluación de nuevos agentes naturales con actividad antiinflamatoria y antiartrítica

    Revista de fitoterapia, Vol. 5, Núm. 1, pp. 82

2004

  1. Potential antipsoriatic avarol derivatives as antioxidants and inhibitors of PGE2 generation and proliferation in the HaCaT cell line

    Journal of Natural Products, Vol. 67, Núm. 9, pp. 1459-1463

2003

  1. Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activation

    British Journal of Pharmacology, Vol. 138, Núm. 8, pp. 1571-1579

  2. Inhibition of the NF-κB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M

    Biochemical Pharmacology, Vol. 65, Núm. 5, pp. 887-895

2001

  1. Dysidotronic acid, a new sesquiterpenoid, inhibits cytokine production and the expression of nitric oxide synthase

    European Journal of Pharmacology, Vol. 415, Núm. 2-3, pp. 285-292

2000

  1. Cavernolide: A new inhibitor of human sPLA2 sharing unusual chemical features

    Life Sciences, Vol. 67, Núm. 24, pp. 3007-3014